Skip to NavigationSkip to content

Pharmafile - Medical Communications News

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that the risks from using Picato are too high to end...
Gilead’s remdesivir, which has been hailed as one of the few truly promising treatments for COVID-19 at this early stage of the ongoing pandemic, has...
Hydroxychloroquine is once again a main feature in the news as it fails a coronavirus clinical trial in France, while the FDA and Novartis have...
National security experts in the UK and US believe China is underreporting the true amount of COVID-19 deaths, but European nations are hesitant to...
President Donald Trump stunned the medical community by suggesting disinfectant and UV light could be used to treat patients suffering from COVID-19.
A study from the National Institutes of Health has shed more light on the efficacy of Gilead’s promising antiviral therapy remdesivir in the fight...
The FDA has warned that they may not be able to sustain its current levels of timely reviews and approvals of marketing applications due to staff...
Moderna has secured $483 million in funding from the Biomedical Advanced Research and Development Authority (BARDA), to drive development and...
Hydroxychloroquine dominates the news as the potential COVID-19 treatment has gone through various trials. A Chinese study showed that the drug does...
The clinical benefit of Gilead’s promising antiviral therapy Remdesivir has been touted in the treatment of severe cases of COVID-19 after anecdotal...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches